Pathfinder Cell Therapy, Inc. (PFND) Return on Investment ROI from the third quarter of 2015 to third quarter of 2014 and for the year 2015, average high and low, overall ranking from Sep 30 2015 to Sep 30 2014 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Pathfinder Cell Therapy, Inc.  (PFND)


Pathfinder Cell Therapy,'s ROI from its third quarter of 2015 to the third quarter of 2014 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Pathfinder Cell Therapy,'s ROI in the third quarter of 2015?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Pathfinder Cell Therapy, Inc.'s return on investment (ROI) in its third quarter of 2015

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2015)
III. Quarter		 (Jun 30 2015)
II. Quarter		 (Mar 31 2015)
I. Quarter		 (Dec 31 2014)
IV. Quarter		 (Sep 30 2014)
III. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -7 -6 -6 -6 -6
Return On Investment (TTM) - - - - -
PFND's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -1 -1 -1 -1 -1

PFND Company Profile >> Back to PFND Roi Comparisons >> See Annual PFND Return On Investment



Return On Investment PFND's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Pathfinder Cell Therapy,'s III. Quarter Investments $ -7 Millions PFND's Balance sheet
Pathfinder Cell Therapy,'s III. Quarter Income $ 0 Millions Quarterly PFND's Income Statement
PFND's Income by Division See PFND's Income by Division


PFND Annual Return On Investment (Dec 31 2014)
2014		 (Dec 31 2013)
2013		 (Dec 31 2012)
2012		 (Dec 31 2010)
2011
Total Investments in Millions -6 -5 -3 -1 0
Y / Y Investment Growth - - - - -
Net Income in Millions -1 -2 -2 -1 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment - - - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PFND's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PFND's Competitors
Subscribers only: Roi for Pathfinder Cell Therapy,'s Suppliers
Subscribers only: Return On Investment for PFND's Customers

Other Ratios
PFND's Roa PFND's Inventory Turnover Ratio PFND's Growth Rates PFND's Dividend Statistics
PFND's Profitability Ratios PFND's Asset Turnover Ratio PFND's Dividend Growth
PFND's Roe PFND's Valuation Ratios PFND's Financial Strength Ratios PFND's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2015, within Healthcare Sector ROI
Abiomed Inc   44.07 %
Corbus Pharmaceuticals Holdings Inc   43.21 %
Fonar Corporation  43.12 %
Proteo Inc  42.96 %
Enanta Pharmaceuticals Inc  37.29 %
Pacific Health Care Organization Inc  36.99 %
Travere Therapeutics Inc   36.12 %
Lannett Company Inc  33.36 %
China Biologic Products Holdings Inc   26.03 %
Iridex Corp  25.61 %
Vanda Pharmaceuticals Inc   25.55 %
Biogen Inc   25.36 %
Lakeland Industries Inc   25.25 %
Mettler toledo International Inc   24.84 %
Biospecifics Technologies Corp  24.67 %
Sientra Inc   24.30 %
Misonix Inc   23.24 %
Journey Medical Corp  22.73 %
Meridian Bioscience Inc   21.54 %
Mimedx Group Inc   21.26 %
Insys Therapeutics, Inc.  19.98 %
Varian Medical Systems Inc   19.98 %
3m Company  19.26 %
Atrion Corporation  18.76 %
Tenax Therapeutics Inc   18.22 %
Retractable Technologies Inc  18.19 %
Oramed Pharmaceuticals Inc  18.19 %
Paratek Pharmaceuticals Inc   17.77 %
Resmed Inc   17.57 %
Illumina Inc   17.56 %

Date modified: 2026-09-08T15:08:00+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.